Resumen
Diferenciales
Común
- Alcohol induced
- Hepatic steatosis
- Primary biliary cholangitis (PBC)
- Primary sclerosing cholangitis
- Hemochromatosis
- Hodgkin lymphoma
- Non-Hodgkin lymphoma (NHL)
- Waldenström macroglobulinemia or lymphoplasmacytic lymphoma
- Acute myeloid leukemia (AML)
- Chronic myeloid leukemia (CML)
- Acute lymphoblastic leukemia (ALL)
- Chronic lymphocytic leukemia (CLL)
- Hairy cell leukemia
- Myelofibrosis
- Polycythemia vera
- Essential thrombocytosis
- Splenic metastases
- Autoimmune hemolytic anemia
- Rheumatoid arthritis (RA)
- Felty syndrome
- Systemic lupus erythematosus
- Sarcoidosis
- Malaria
- Epstein-Barr virus (EBV)
- Endocarditis
- Sepsis-related splenic abscesses
- Chronic hepatitis C
- Chronic hepatitis B
- Sickle cell anemia
- Cytoskeletal defects
- Thalassemias
Infrecuente
- Benign splenic tumors
- Portal vein thrombosis
- Splenic vein thrombosis
- Budd-Chiari syndrome
- Hemophagocytic lymphohistiocytosis (HLH)
- Amyloidosis
- Gaucher or Niemann-Pick disease
- Severe dengue
- Splenic rupture
- Subcapsular hemorrhage
- Secondary to granulocyte colony-stimulating factor (G-CSF)
Colaboradores
Autores
Terri L. Parker, MD
Assistant Professor of Medicine
Section of Hematology
Yale School of Medicine
Smilow Cancer Center at Yale-New Haven
New Haven
CT
Divulgaciones
TLP declares that she has no competing interests.
Agradecimientos
Dr Terri L. Parker would like to gratefully acknowledge Dr Alan E. Lichtin, the previous contributor to this monograph.
Divulgaciones
AEL has received research support from Amgen.
Revisores por pares
Priyanka Mehta, MD
Consultant Haematologist
Bristol Haematology and Oncology Centre
Bristol
UK
Divulgaciones
PM declares that she has no competing interests.
Ruben A. Mesa, MD
Professor of Medicine
Mayo Clinic
Scottsdale
AZ
Divulgaciones
RAM declares that he has no competing interests.
Giovanni Barosi, MD
Director of the Laboratory of Clinical Epidemiology
IRCCS Policlinico S. Matteo Foundation
Pavia
Italy
Divulgaciones
GB declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referencias
Artículos principales
Gertz MA. Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management. Am J Hematol. 2023 Feb;98(2):348-58.Texto completo Resumen
Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022 Jul;36(7):1720-48.Texto completo Resumen
Shakoory B, Geerlinks A, Wilejto M, et al. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS). Ann Rheum Dis. 2023 Oct;82(10):1271-85.Texto completo Resumen
Kowdley KV, Brown KE, Ahn J, et al. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019 Aug;114(8):1202-18.Texto completo Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Folletos para el paciente
Hepatitis B: should I have the vaccine?
Hepatitis C: what is it?
Más Folletos para el pacienteInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad